Cargando…
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization
NRG1 fusions are recurrent somatic genome alterations occurring across several tumor types, including invasive mucinous lung adenocarcinomas and pancreatic ductal adenocarcinomas and are potentially actionable genetic alterations in these cancers. We initially discovered CD74-NRG1 as the first NRG1...
Autores principales: | Werr, Lisa, Plenker, Dennis, Dammert, Marcel A., Lorenz, Carina, Brägelmann, Johannes, Tumbrink, Hannah L., Klein, Sebastian, Schmitt, Anna, Büttner, Reinhard, Persigehl, Thorsten, Shokat, Kevan M., Wunderlich, F. Thomas, Schram, Alison M., Peifer, Martin, Sos, Martin L., Reinhardt, H. Christian, Thomas, Roman K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377738/ https://www.ncbi.nlm.nih.gov/pubmed/35247925 http://dx.doi.org/10.1158/1535-7163.MCT-21-0820 |
Ejemplares similares
-
Increased NRG1-ErbB4 signaling in human symptomatic epilepsy
por: Zhu, Jun-Ming, et al.
Publicado: (2017) -
NRG4-ErbB4 signaling represses proinflammatory macrophage activity
por: Schumacher, Michael A., et al.
Publicado: (2021) -
Cartilage regeneration in zebrafish depends on Nrg1/ErbB signaling pathway
por: Sapède, Dora, et al.
Publicado: (2023) -
Expression and Localization of Neuregulin-1 (Nrg1) and ErbB2/ErbB4 Receptors in Main Endocrine Organs of the Rhesus Monkey
por: Zhao, Wei-jiang
Publicado: (2013) -
miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling
por: Shi, Dong-Min, et al.
Publicado: (2018)